Dr. Tina Sampalis Named Chief Scientific Officer Of Tersus Life Sciences

 BONITA SPRINGS, Fla., Feb. 29, 2016 /PRNewswire/ -- Tina Sampalis, M.D., PhD., has joined Tersus Life Sciences LLC ("Tersus"), as Chief Scientific Officer. Dr. Sampalis is an Oncology Surgeon and was trained in the fields of Physiology, Dermatology, and Pediatric General and Oncology Surgery.

Dr. Sampalis has Ph.D.'s in Surgical Research, Epidemiology and Experimental Surgery. Dr. Sampalis is a member of the American Association of Naturopathic Medicine and the named inventor of numerous omega-3 phospholipid composition and method patents, has authored numerous studies and peer-reviewed publications worldwide.

Dr. Sampalis has been named among 100 most successful women, globally, by the Princeton Global Network.

Dr. Sampalis joins Tersus Life Sciences following 15 years with Neptune Technologies and Bioresources as Chief Scientific Officer and President of Acasti Pharma. Dr. Sampalis discovered and successfully pioneered krill oil and her research demonstrated the advantages of krill oil omega-3 phospholipids, well recognized today by academia and worldwide markets. Dr. Sampalis is the catalyst for the success of such krill oil based products as Mega Red Krill Oil to global markets.

Dr. Sampalis will provide leadership, oversight and governance of Tersus' patent estate, present and future clinical studies, product innovations and global positioning of Tersus' Provinal® products. Provinal® Omega 7 is a naturally occurring highly purified monounsaturated fatty acid with a broad range of scientifically and clinically proven health indications, bridging the treatment gap in lipid management.

"I am very excited to work with innovative products and a company like Tersus, that recognizes and respects the importance of science and the value of a strong patent portfolio. I believe together, we will surprise the world once again with Provinal® Omega 7, an innovation that we can substantiate with clinical evidence and good science."

Timothy Gooding, Chairman of Tersus states, "We enthusiastically welcome Dr. Tina Sampalis to Tersus and we are excited to work with a world renowned expert in omega-3 phospholipid science, positioning Tersus in the forefront as an innovator in the field of monounsaturated fatty acids."

Tersus Life Sciences LLC ("Tersus"), is a US based bio-life science company dedicated to the research, development and commercialization of Provinal® Omega 7, a novel, patented and clinically substantiated monounsaturated fatty-acid ingredient targeting the prevention and reversal of dyslipidemia, and cardiometabolic disorders.


Connie Dease @ Tersus Life Sciences LLC 1.239.390.1226 [email protected]

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/dr-tina-sampalis-named-chief-scientific-officer-of-tersus-life-sciences-300226891.html

SOURCE Tersus Life Sciences LLC

Suggested Articles

Biogen unveiled full phase 1/2 for a prospect that emerged from a shift in its thinking about treating amyotrophic lateral sclerosis.

It took a little longer than expected, but Biogen’s done it—along with partner Eisai, the Big Biotech has completed an FDA filing for aducanumab.

Gilead is ditching a new avenue of treating hepatitis B as it cuts ties with Precision Biosciences less than two years into their research pact.